386 related articles for article (PubMed ID: 24182427)
1. Dengue virus infection: current concepts in immune mechanisms and lessons from murine models.
Guabiraba R; Ryffel B
Immunology; 2014 Feb; 141(2):143-56. PubMed ID: 24182427
[TBL] [Abstract][Full Text] [Related]
2. Mouse models of dengue virus infection and disease.
Yauch LE; Shresta S
Antiviral Res; 2008 Nov; 80(2):87-93. PubMed ID: 18619493
[TBL] [Abstract][Full Text] [Related]
3. IL-22 modulates IL-17A production and controls inflammation and tissue damage in experimental dengue infection.
Guabiraba R; Besnard AG; Marques RE; Maillet I; Fagundes CT; Conceição TM; Rust NM; Charreau S; Paris I; Lecron JC; Renauld JC; Quesniaux V; Da Poian AT; Arruda LB; Souza DG; Ryffel B; Teixeira MM
Eur J Immunol; 2013 Jun; 43(6):1529-44. PubMed ID: 23505056
[TBL] [Abstract][Full Text] [Related]
4. A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease.
Sarathy VV; White M; Li L; Gorder SR; Pyles RB; Campbell GA; Milligan GN; Bourne N; Barrett AD
J Virol; 2015 Jan; 89(2):1254-66. PubMed ID: 25392217
[TBL] [Abstract][Full Text] [Related]
5. A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection.
Renneson J; Guabiraba R; Maillet I; Marques RE; Ivanov S; Fontaine J; Paget C; Quesniaux V; Faveeuw C; Ryffel B; Teixeira MM; Trottein F
Am J Pathol; 2011 Oct; 179(4):1872-83. PubMed ID: 21843496
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional Profiling Confirms the Therapeutic Effects of Mast Cell Stabilization in a Dengue Disease Model.
Morrison J; Rathore APS; Mantri CK; Aman SAB; Nishida A; St John AL
J Virol; 2017 Sep; 91(18):. PubMed ID: 28659489
[TBL] [Abstract][Full Text] [Related]
7. Dengue Virus M Protein Promotes NLRP3 Inflammasome Activation To Induce Vascular Leakage in Mice.
Pan P; Zhang Q; Liu W; Wang W; Lao Z; Zhang W; Shen M; Wan P; Xiao F; Liu F; Zhang W; Tan Q; Liu X; Wu K; Liu Y; Li G; Wu J
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413130
[TBL] [Abstract][Full Text] [Related]
8. Immunological and Pathological Landscape of Dengue Serotypes 1-4 Infections in Immune-Competent Mice.
Rathore APS; Mantri CK; Tan MW; Shirazi R; Nishida A; Aman SAB; Morrison J; St John AL
Front Immunol; 2021; 12():681950. PubMed ID: 34168651
[TBL] [Abstract][Full Text] [Related]
9. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.
Elong Ngono A; Shresta S
Front Immunol; 2019; 10():1316. PubMed ID: 31244855
[TBL] [Abstract][Full Text] [Related]
10. Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models.
Tang WW; Grewal R; Shresta S
Curr Opin Virol; 2015 Aug; 13():61-6. PubMed ID: 26001278
[TBL] [Abstract][Full Text] [Related]
11. Experimental in vitro and in vivo systems for studying the innate immune response during dengue virus infections.
Kitab B; Kohara M; Tsukiyama-Kohara K
Arch Virol; 2018 Jul; 163(7):1717-1726. PubMed ID: 29520688
[TBL] [Abstract][Full Text] [Related]
12. Dengue Virus-Infected Dendritic Cells, but Not Monocytes, Activate Natural Killer Cells through a Contact-Dependent Mechanism Involving Adhesion Molecules.
Costa VV; Ye W; Chen Q; Teixeira MM; Preiser P; Ooi EE; Chen J
mBio; 2017 Aug; 8(4):. PubMed ID: 28765218
[TBL] [Abstract][Full Text] [Related]
13. Immune responses to dengue virus in the skin.
Rathore APS; St John AL
Open Biol; 2018 Aug; 8(8):. PubMed ID: 30135238
[TBL] [Abstract][Full Text] [Related]
14. Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.
Züst R; Toh YX; Valdés I; Cerny D; Heinrich J; Hermida L; Marcos E; Guillén G; Kalinke U; Shi PY; Fink K
J Virol; 2014 Jul; 88(13):7276-85. PubMed ID: 24741106
[TBL] [Abstract][Full Text] [Related]
15. Establishment of Murine Infection Models with Biological Clones of Dengue Viruses Derived from a Single Clinical Viral Isolate.
Zheng Z; Li M; Liu Z; Jin X; Sun J
Virol Sin; 2020 Oct; 35(5):626-636. PubMed ID: 32451883
[TBL] [Abstract][Full Text] [Related]
16. IFN-γ production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner.
Fagundes CT; Costa VV; Cisalpino D; Amaral FA; Souza PR; Souza RS; Ryffel B; Vieira LQ; Silva TA; Atrasheuskaya A; Ignatyev G; Sousa LP; Souza DG; Teixeira MM
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1449. PubMed ID: 22206036
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a murine model of non-lethal, symptomatic dengue virus infection.
Sarathy VV; White M; Li L; Kaiser JA; Campbell GA; Milligan GN; Bourne N; Barrett ADT
Sci Rep; 2018 Mar; 8(1):4900. PubMed ID: 29559699
[TBL] [Abstract][Full Text] [Related]
18. Innate Antiviral Immunity against Dengue Virus.
Makhluf H; Shresta S
Crit Rev Immunol; 2015; 35(3):253-60. PubMed ID: 26559229
[TBL] [Abstract][Full Text] [Related]
19. A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice.
Milligan GN; Sarathy VV; Infante E; Li L; Campbell GA; Beatty PR; Harris E; Barrett AD; Bourne N
PLoS One; 2015; 10(5):e0125476. PubMed ID: 25938762
[TBL] [Abstract][Full Text] [Related]
20. Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice.
Costa VV; Fagundes CT; Valadão DF; Ávila TV; Cisalpino D; Rocha RF; Ribeiro LS; Ascenção FR; Kangussu LM; Celso MQ; Astigarraga RG; Gouveia FL; Silva TA; Bonaventura D; Sampaio Dde A; Leite AC; Teixeira MM; Souza DG
Med Microbiol Immunol; 2014 Aug; 203(4):231-50. PubMed ID: 24723052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
